Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19 Vaccines Safety Tracking (CoVaST)
Sponsor: Masaryk University
Summary
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Official title: COVID-19 Vaccines Safety Tracking: Global Consortium Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30000
Start Date
2021-04-01
Completion Date
2026-12-31
Last Updated
2022-04-06
Healthy Volunteers
No
Interventions
BNT162b2
Receiving either the first dose only or both doses of BNT162b2 vaccine (Pfizer-BioNTech COVID-19 Vaccine)
mRNA-1273
Receiving either the first dose only or both doses of mRNA-1273 vaccine (Moderna COVID-19 Vaccine)
AZD1222
Receiving either the first dose only or both doses of AZD1222 vaccine (AstraZeneca-Oxford University COVID-19 Vaccine)
CoronaVac
Receiving either the first dose only or both doses of CoronaVac (Sinovac COVID-19 Vaccine)
Sinopharm
Receiving either the first dose only or both doses of Sinopharm Vero Cell COVID-19 Vaccine
Gam-COVID-Vac
Receiving either the first dose only or both doses of Gam-COVID-Vac (Sputnik V)
JNJ-78436735
Receiving JNJ-78436735 (Janssen COVID-19 Vaccine)
CVnCoV
Receiving either the first dose only or both doses of CVnCoV (CureVac COVID-19 vaccine)
NVX-CoV2373
Receiving either the first dose only or both doses of NVX-CoV2373 (Novavax COVID-19 vaccine)
BBV152
Receiving either the first dose only or both doses of BBV152 (Covaxin COVID-19 vaccine)
Locations (14)
American College of Physicians
Philadelphia, Pennsylvania, United States
McMaster University
Hamilton, Ontario, Canada
University of Split
Split, Croatia
Masaryk University
Brno, Czechia
University of Tartu
Tartu, Estonia
Jimma University
Jimma, Ethiopia
Justus-Liebig University Giessen
Giessen, Germany
University of Ghana
Accra, Ghana
Sinaloa's Pediatric Hospital
Culiacán, Mexico
Medical University of Silesia
Katowice, Poland
Nursing School of Coimbra
Coimbra, Portugal
Irkutsk Scientific Center of Siberian Branch of Russian Academy of Sciences
Irkutsk, Russia
University of Belgrade
Belgrade, Serbia
University of Ljubljana
Ljubljana, Slovenia